Literature DB >> 31931564

Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks.

Mram Z Alyami1, Shahad K Alsaiari1, Yanyan Li2, Somayah S Qutub1, Fajr A Aleisa2, Rachid Sougrat3, Jasmeen S Merzaban2, Niveen M Khashab1.   

Abstract

Effective and cell-type-specific delivery of CRISPR/Cas9 gene editing elements remains a challenging open problem. Here we report the development of biomimetic cancer cell coated zeolitic imidazolate frameworks (ZIFs) for targeted and cell-specific delivery of this genome editing machinery. Coating ZIF-8 that is encapsulating CRISPR/Cas9 (CC-ZIF) with a cancer cell membrane resulted in the uniformly covered C3-ZIF(cell membrane type). Incubation of C3-ZIFMCF with MCF-7, HeLa, HDFn, and aTC cell lines showed the highest uptake by MCF-7 cells and negligible uptake by the healthy cells (i.e., HDFn and aTC). As to genome editing, a 3-fold repression in the EGFP expression was observed when MCF-7 were transfected with C3-ZIFMCF compared to 1-fold repression in the EGFP expression when MCF-7 were transfected with C3-ZIFHELA. In vivo testing confirmed the selectivity of C3-ZIFMCF to accumulate in MCF-7 tumor cells. This supports the ability of this biomimetic approach to match the needs of cell-specific targeting, which is unquestionably the most critical step in the future translation of genome editing technologies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31931564     DOI: 10.1021/jacs.9b11638

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

Review 1.  Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery.

Authors:  Justin M Horn; Allie C Obermeyer
Journal:  Biomacromolecules       Date:  2021-12-02       Impact factor: 6.978

Review 2.  New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

Authors:  Maja van Hees; Sofie Slott; Anders Højgaard Hansen; Heon Seok Kim; Hanlee P Ji; Kira Astakhova
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 11.454

Review 3.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  Gene Delivery Technologies with Applications in Microalgal Genetic Engineering.

Authors:  Sergio Gutiérrez; Kyle J Lauersen
Journal:  Biology (Basel)       Date:  2021-03-26

5.  Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo.

Authors:  Zhengwei Liu; Faming Wang; Xinping Liu; Yanjuan Sang; Lu Zhang; Jinsong Ren; Xiaogang Qu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

6.  In situ assembled ZIF superstructures via an emulsion-free soft-templating approach.

Authors:  Namita Singh; Sana Ahmed; Aliyah Fakim; Somayah Qutub; Othman Alahmed; Omar El Tall; Osama Shekhah; Mohamed Eddaoudi; Niveen M Khashab
Journal:  Chem Sci       Date:  2020-09-22       Impact factor: 9.825

Review 7.  Spatiotemporal control of CRISPR/Cas9 gene editing.

Authors:  Chenya Zhuo; Jiabin Zhang; Jung-Hwan Lee; Ju Jiao; Du Cheng; Li Liu; Hae-Won Kim; Yu Tao; Mingqiang Li
Journal:  Signal Transduct Target Ther       Date:  2021-06-20

8.  Lipid- and Polymer-Based Nanoparticle Systems for the Delivery of CRISPR/Cas9.

Authors:  Bhaargavi Ashok; Nicholas A Peppas; Marissa E Wechsler
Journal:  J Drug Deliv Sci Technol       Date:  2021-07-11       Impact factor: 5.062

9.  ZnAl nano layered double hydroxides for dual functional CRISPR/Cas9 delivery and enhanced green fluorescence protein biosensor.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Ghazal Salehi; Yousef Fatahi; Rassoul Dinarvand
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

Review 10.  Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.

Authors:  Karim Shalaby; Mustapha Aouida; Omar El-Agnaf
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.